Ribociclib
Novartis
['breast', ' ribo', 'ribociclib']
the combination of ribociclib and endocrine therapy has already been shown to yield a significant survival advantage for women with metastatic, hr+/her2- #breastcancer. #asco23 
Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.